نتایج جستجو برای: transarterial chemoembolization
تعداد نتایج: 4521 فیلتر نتایج به سال:
Cadonilimab is the first bi-specific antibody approved for certain malignancies in June 2022, which has a modified Fc structure to reduce immune-related adverse events. To date, no reports have described Cadonilimab-related toxic epidermal necrolysis (TEN). Here, we report case of TEN-like reactions occurring during treatment hepatocellular carcinoma with combination Lenvatinib and transarteria...
HYPOTHESIS Patients with bilobar stage IVa hepatocellular carcinoma (HCC) are generally considered unsuitable for hepatic resection. Recent data suggest that palliative hepatic resection in selected patients with advanced HCC may result in a favorable survival outcome. The aim of the present study was to evaluate the operative outcome and survival benefits of hepatic resection for patients with...
Introduction: Transarterial Chemoembolization (TACE) is one of the palliative treatments offered in patients staged Barcelona Clinic Liver Cancer (BCLC) B. TACE can lead to many complications, like decompensation liver, liver abscess, rupture, femoral artery pseudoaneurysm and gallbladder pathology. Methods: We report a case 58-year old gentleman, which developed extensive portal vein thrombosi...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید